Compare ATS & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATS | TWST |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2007 | 2018 |
| Metric | ATS | TWST |
|---|---|---|
| Price | $33.97 | $58.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $35.00 | ★ $46.88 |
| AVG Volume (30 Days) | 103.1K | ★ 1.2M |
| Earning Date | 05-27-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $17.99 | $18.91 |
| Revenue Next Year | $4.52 | $15.07 |
| P/E Ratio | $222.92 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $23.85 | $23.30 |
| 52 Week High | $33.53 | $66.06 |
| Indicator | ATS | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 58.78 |
| Support Level | $26.65 | $41.85 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.96 | 3.43 |
| MACD | 0.43 | 0.90 |
| Stochastic Oscillator | 95.88 | 57.04 |
ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.